XCURES-GAM Glioblastoma, Expanded access to Gallium Maltolate (GAM): must have exhausted or had inadequate response to available anti-cancer treatments
- Trial Category: Brain Tumors
Contact(s)
Mary Beth Wilwerding, RN Admin@NEcancertrials.com
Location(s)
Available at Cancer Partners of Nebraska, Lincoln, NE location
About
study has limited slots, and the sponsor must approve participation
Interested in More Information?
Please fill out the form below. Someone will get back to you as soon as possible.
"*" indicates required fields